NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
52 hedge funds and large institutions have $22.9M invested in NeuBase Therapeutics, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 15 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
13% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 15
Holders
52
Holding in Top 10
–
Calls
$3.27M
Puts
$1.57M
Top Buyers
| 1 | +$1.02M | |
| 2 | +$851K | |
| 3 | +$469K | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$356K |
| 5 |
Neuberger Berman Group
New York
|
+$284K |
Top Sellers
| 1 | -$720K | |
| 2 | -$331K | |
| 3 | -$186K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$167K |
| 5 |
BHA
Beech Hill Advisors
New York
|
-$106K |